You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR ENTECAVIR

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for entecavir

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00035633 ↗	A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen	Completed	Bristol-Myers Squibb	Phase 3	2001-12-01	The purpose of this clinical research study is to assess the safety effectiveness of entecavir, as compared to lamivudine, in the treatment of adults with chronic hepatitis B infection who are hepatitis B e antigen positive.
NCT00035789 ↗	A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen	Completed	Bristol-Myers Squibb	Phase 3	2001-11-01	The purpose of this clinical research study is to assess the safety and effectiveness of entecavir, as compared to lamivudine, in the treatment of adults with chronic hepatitis B infection who are hepatitis B e antigen negative.
NCT00036608 ↗	A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine	Completed	Bristol-Myers Squibb	Phase 3	2002-01-01	The purpose of this clinical research study is to assess the safety and effectiveness of switching to entecavir compared to continued lamivudine in patients with chronic hepatitis B.
NCT00051038 ↗	Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients	Completed	Bristol-Myers Squibb	Phase 2/Phase 3	2002-09-01	The purpose of this clinical research study is to assess the safety and effectiveness of entecavir, when being added to lamivudine, in the treatment of adults with chronic hepatitis B infection who are co-infected with HIV.
NCT00065507 ↗	Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation	Completed	Bristol-Myers Squibb	Phase 3	2003-08-01	This is a phase IIIb comparative study of entecavir 1.0 mg once daily (QD) vs. adefovir 10 mg QD in patients who have chronic hepatitis B infection and hepatic decompensation. The patients are treated for 96 weeks after the last subject is randomized.
NCT00096785 ↗	Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection	Completed	Bristol-Myers Squibb	Phase 3	2004-12-01	The purpose of this study is to evaluate antiviral activity and efficacy of entecavir (ETV) compared to adefovir in adults with chronic hepatitis B who have not been treated yet with an antiviral medicine.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for entecavir

Condition Name

Chart
Table

Condition Name for entecavir
Intervention	Trials
Chronic Hepatitis B	85
Hepatitis B, Chronic	48
Hepatitis B	42
HBV	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for entecavir
Intervention	Trials
Hepatitis B	218
Hepatitis	200
Hepatitis A	172
Hepatitis B, Chronic	170
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for entecavir

Trials by Country

Map
Table

Trials by Country for entecavir
Location	Trials
China	289
United States	254
Korea, Republic of	68
Taiwan	46
Japan	36
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for entecavir
Location	Trials
California	24
New York	21
Maryland	17
Texas	17
Florida	16
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for entecavir

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for entecavir
Clinical Trial Phase	Trials
Phase 4	93
Phase 3	35
Phase 2/Phase 3	3
[disabled in preview]	73
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for entecavir
Clinical Trial Phase	Trials
Completed	93
Unknown status	63
Recruiting	37
[disabled in preview]	45
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for entecavir

Sponsor Name

Chart
Table

Sponsor Name for entecavir
Sponsor	Trials
Bristol-Myers Squibb	33
National Taiwan University Hospital	12
Sun Yat-sen University	9
[disabled in preview]	25
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for entecavir
Sponsor	Trials
Other	395
Industry	130
NIH	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.